Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Zepp Health's Revenue for the
three
months ended in Mar. 2026 was €44.6 Mil. Zepp Health's average Accounts Receivable for the
three
months ended in Mar. 2026 was €52.9 Mil.
Hence, Zepp Health's Receivables Turnover for the
three
months ended in Mar. 2026 was 0.84.
Zepp Health (FRA:ST0) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Zepp Health Receivables Turnover Related Terms
Zepp Health Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Zepp Health's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:ST0 vs UEIC, AXIL, KOSS: Receivables Turnover Comparison
For the Consumer Electronics subindustry, Zepp Health's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zepp Health Receivables Turnover vs Hardware Industry
For the Hardware industry and Technology sector, Zepp Health's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Zepp Health's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zepp Health (FRA:ST0) has a Receivables Turnover of 0.84 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Zepp Health and its competitors. According to the industry distribution chart, Zepp Health ranks #1555 out of 2472 companies in the Hardware industry, placing it in the top 62.9%.
Is Zepp Health's Receivables Turnover too high?
Zepp Health's current Receivables Turnover is 0.84. The Hardware industry median Receivables Turnover is 4.90. Zepp Health's value of 0.84 is 82.8% below this industry median. Based on the distribution chart, Zepp Health ranks #1555 out of 2472 companies in the Hardware industry, which is below the industry midpoint. Overall, Zepp Health has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zepp Health's Receivables Turnover compare to UEIC and AXIL?
According to the Hardware industry distribution chart, Zepp Health ranks #1555 out of 2472 companies for Receivables Turnover. This places Zepp Health in the lower half of its industry. The industry median Receivables Turnover is 4.90. Zepp Health's value of 0.84 is 82.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Hardware company?
The median Receivables Turnover among Hardware companies is 4.90, based on 2,472 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zepp Health's current Receivables Turnover of 0.84 is 82.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Zepp Health and its competitors. For the Hardware industry, the median Receivables Turnover is 4.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zepp Health's current Receivables Turnover is 0.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zepp Health stock overvalued right now?
Based on GuruFocus' analysis, Zepp Health (FRA:ST0) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.45, compared to a current price of €4.54 — trading 31.6% above its estimated fair value. The current Receivables Turnover is 0.84 and 82.8% below the Hardware industry median of 4.90. Zepp Health's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Zepp Health (FRA:ST0), the current Receivables Turnover is 0.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zepp Health (FRA:ST0) Overvalued in 2026?
Based on GuruFocus' analysis, Zepp Health stock appears to be overvalued.
The current stock price of €4.54 is trading 31.6% above its estimated GF Value™ of €3.45.
GuruFocus considers Zepp Health to be Significantly Overvalued.
Key valuation signals for FRA:ST0:
Receivables Turnover: 0.84
GF Value™: €3.45 vs. price of €4.54 (31.6% above fair value)
Industry Position: 82.8% below the Hardware median (#1555 of 2472)
No single metric tells the full story. See the FRA:ST0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.
45GF Score
Get the complete analysis for FRA:ST0
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ST0 has been successfully added to your 
